Christina L Roland
Overview
Explore the profile of Christina L Roland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
3177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morris Z, Demaria S, Monjazeb A, Formenti S, Weichselbaum R, Welsh J, et al.
Lancet Oncol
. 2025 Mar;
26(3):e152-e170.
PMID: 40049206
Radiotherapy both promotes and antagonises tumour immune recognition. Some clinical studies show improved patient outcomes when immunotherapies are integrated with radiotherapy. Safe, greater than additive, clinical response to the combination...
2.
Wang L, Li R, Wen A, Lu Q, Wang J, Ruan X, et al.
medRxiv
. 2025 Mar;
PMID: 40034771
Understanding the disease trajectories of specific diseases can provide important clinical insights. In this paper, we aimed to discover signature disease trajectories of 3 rare cancer types: pancreatic cancer, soft...
3.
Roland C, Bonvalot S
Eur J Surg Oncol
. 2025 Jan;
51(5):109609.
PMID: 39862838
No abstract available.
4.
Tomczak K, Patel M, Bhalla A, Peterson C, Landers S, Callahan S, et al.
Mol Carcinog
. 2024 Nov;
64(1):44-56.
PMID: 39600120
Malignant peripheral nerve sheath tumor (MPNST) development is characterized by an altered DNA methylation landscape, which presents a promising area for developing MPNST-specific biomarkers for screening patients with NF1. Genome-wide...
5.
Haddox C, Hornick J, Roland C, Baldini E, Keedy V, Riedel R
Cancer Treat Rev
. 2024 Oct;
131:102846.
PMID: 39454547
Dedifferentiated liposarcoma (DDLPS) is a malignant mesenchymal neoplasm in desperate need of novel therapeutic approaches. Often occurring in conjunction with well-differentiated liposarcoma (WDLPS), DDLPS can behave more aggressively and exhibits...
6.
Lyu H, Roland C, Scally C
Ann Surg Oncol
. 2024 Sep;
31(13):9285-9286.
PMID: 39320401
No abstract available.
7.
Bonvalot S, Roland C
Ann Surg Oncol
. 2024 Sep;
31(12):7967-7968.
PMID: 39230852
No abstract available.
8.
Lyu H, Witt R, Rajkot N, Keung E, Torres K, Hunt K, et al.
Ann Surg Oncol
. 2024 Sep;
31(13):9258-9264.
PMID: 39230849
Background: The course of subclinical gastrointestinal stromal tumors (GISTs) is variable. The management of small GISTs is not well-defined. Methods: Records of patients presenting with small GISTs with documented follow-up...
9.
Bishop A, Mitra D, Farooqi A, Swanson D, Hempel C, Willis T, et al.
Cancer
. 2024 Aug;
131(1):e35542.
PMID: 39192597
Background: Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS; ClinicalTrials.gov identifier NCT03819985) investigated a radiobiologically equivalent, moderately hypofractionated course of preoperative radiotherapy (RT) 15 × 2.85 Gy...
10.
Gingrich A, Wangsiricharoen S, Torres M, Ravi V, Ratan R, Keung E, et al.
Ann Surg Oncol
. 2024 Aug;
31(12):7950-7956.
PMID: 39150618
Background: Atypical intradermal smooth muscle neoplasm, also commonly termed cutaneous leiomyosarcoma, is a soft tissue tumor with a low risk of aggressive behavior. These lesions arise in the dermis with...